A full study testing dexamethasone — a cheap, widely available steroid — as a treatment for COVID-19 found that the drug reduced mortality rates among patients on ventilators or who were receiving ...
Author(s)Goldschmidt H, Moreau P, Ludwig H, et al. Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ...
A dexamethasone-sparing regimen involving lenalidomide (Revlimid) and the anti-CD38 drug daratumumab (Darzalex) was safe and effective in older, frail patients with newly diagnosed multiple myeloma, ...
Dexamethasone may help save up to one-third of patients on ventilators. As the world awaits a COVID-19 vaccine, researchers studying possible treatments have found a commonly used steroid called ...
Infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the virus responsible for the present coronavirus disease 2019 (COVID-19) pandemic, causes a wide spectrum of ...
As the coronavirus continues to spread around the globe, companies and academic labs are racing to develop a vaccine that would help society get back to normal. But there could also be costs to moving ...
A British trial showing that a common steroid could reduce deaths in severe COVID-19 cases by one-third was good news for Minnesota physicians who have been battling the infectious disease without a ...
As effects of glucocorticoids differ with respect to preparation, dose and duration, we hypothesized that a postnatal regimen of a low-dose, short-course betamethasone treatment had comparable ...
The IMiD lenalidomide has shown promising results as a single agent 16 as well as in combination with other active agents for the treatment of MM. 15, 17, 18, 19, 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback